Our Website Uses Cookies 


We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.


For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

David Wildman
David R. Wildman
Associate
New York +1 212 841 1202 dwildman@cov.com Download V-card

David Wildman specializes in complex transactions involving technology, intellectual property, and data. In this role, he regularly advises clients on issues relating to data commercialization, IP licensing, software development, and information technology services (such as cloud services, IT procurement, and outsourcing). Mr. Wildman, who is a registered Patent Attorney and former electrical engineer, also advises on the intellectual property aspects of mergers, acquisitions, and strategic investments. Mr. Wildman represents clients in a wide array of industries, including health technology, travel, and finance.

In addition to his broader practice, Mr. Wildman is a member of Covington’s Digital Health Initiative. In that capacity, he counsels pharmaceutical, medical device, and technology companies on the complex commercial and intellectual property considerations that arise at the intersection of information technology, life sciences, and healthcare. These considerations include patient privacy and data security, ownership of data and derived insights, service levels, the development and exploitation of “Big Data” analytical tools and predictive models, and FDA-readiness, as well as other commercial issues that arise when entering into a partnership, collaboration or other strategic arrangement with participants in the digital health sector.

  • GlaxoSmithKline on its multi-year drug target discovery and development collaboration with 23andMe.
  • Teva Pharmaceutical Industries in its strategic partnership with IBM, including the deployment of IBM’s Watson Health Cloud as Teva’s global patient technology platform.
  • American Airlines in technology and data distribution agreements with travel industry participants.
  • Various airlines in connection with agency agreements, data commercialization agreements, data distribution agreements, and IT services agreements.
  • A multinational biopharmaceutical company in connection with an acquisition of a biotechnology company specializing in CRISPR-based technologies for target discovery.
  • A major pharmaceutical company on its agreements relating to the sequencing of genomic data sets from the UK Biobank.
  • An emerging digital health company as product counsel for its cancer treatment platform, including the development of template partner and customer agreements.
  • A cloud services company, with a genome informatics and data management platform, in connection with a gene sequencing collaboration agreement, material transfer agreements and terms for data analytics challenges.
  • A subsidiary of a major pharmaceutical company in development and collaboration agreements with various EHR platform providers.
  • A pharmaceutical company in a data licensing agreement with a health analytics firm.
  • A biotech company in an intellectual property licensing agreement with a product manufacturer.
  • A pharmaceutical company with its Terms of Service and Privacy Policy for a suite of mobile health apps and websites.
  • An aerospace company in a licensing dispute with a software vendor.
  • A travel industry client in connection with IP due diligence and technology transfer and licensing agreements.

Pro Bono

  • Obtained Special Immigrant Juvenile Status (SIJS) for a minor from El Salvador in removal proceedings.
  • Obtained cancellation of removal for a 30-year legal permanent resident in removal proceedings.
  • Advised a 501(c)(3) organization in connection with an agreement for customer relationship management (CRM) software and consulting services.
  • Advised the founder of a fitness company directed at low income individuals on corporate and intellectual property matters, including with respect to entity formation, trademark filings, client agreements, and publicity waivers. 

Previous Experience

  • Performed IP due diligence on behalf of an investor participating in a Series C funding round of a medical device company.
  • Facilitated the development of a global licensing program, involving thousands of IP assets, for a leading media company.
  • Represented a Fortune 500 company in an inter partes review at the USPTO.